Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Theranostics|October 4, 2018
ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapyZhanwei Zhou, Qingyan Zhang, Minghua Zhang, et al.
Critical Reviews in Biotechnology|November 26, 2021
Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnologyRaj Kumar, Keshaw Ram Aadil, Kunal Mondal, et al.
Plos One|May 19, 2017
Correction: Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047Tracy Murray-Stewart, Elena Ferrari, Ying Xie, et al.
Pharmaceutical Research|August 24, 2010
Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquineShanta Raj Bhattarai, Elayaraja Muthuswamy, Amit Wani, et al.
Plos One|April 20, 2017
Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047Tracy Murray-Stewart, Elena Ferrari, Ying Xie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2019
Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA NanoemulsionsZhaoting Li, Gang Chen, Ling Ding, et al.
ACS Applied Materials & Interfaces|April 11, 2017
Bioreducible Cross-Linked Hyaluronic Acid/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor TherapyZhanwei Zhou, Huipeng Li, Kaikai Wang, et al.
Case Reports in Oncology|May 3, 2019
Highly Aggressive and Radiation-Resistant, "Atypical" and Silent Pituitary Corticotrophic Carcinoma: A Case Report and Review of the LiteratureLaura Flores, Richard Sleightholm, Beth Neilsen, et al.
Medical Sciences (Basel, Switzerland)|August 23, 2022
Polyamine-Based Nanostructures Share Polyamine Transport Mechanisms with Native Polyamines and Their Analogues: Significance for Polyamine-Targeted TherapyCassandra E Holbert, Jackson R Foley, Ao Yu, et al.
Biomacromolecules|February 28, 2018
Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer TherapyRuvanthi N Kularatne, Katherine E Washington, Chandima Bulumulla, et al.
Pageof 6